Loading provider…
Loading provider…
Hematology & Oncology Physician in Washington, DC
NPI: 1558455378Primary Practice Location
MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL
3800 Reservoir Rd NW, Washington, DC
Primary Employer
Mgmc, LLC
mgmcltd.co.uk
HQ Phone
Get MBBS, MD, MPH George's Phone Numberphone_androidMobile
Get MBBS, MD, MPH George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 134 | 307 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 87 | 321 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 56 | 56 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 26 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
Authors: Taber, Ann, Park, Youngrok, Lelo, Alana, Prip, Frederik, Xiao, Jerry, Berry, Deborah L, Chaldekas, Krysta, Jensen, Jørgen Bjerggaard, Philips, George, Kim, Jung-Sik, Harris, Brent T, Dyrskjøt, Lars, Waldman, Todd
Journal: Urol Oncol
Publication Date: 2021-03-10
Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma?
Authors: Philips, George, Atkins, Michael B
Journal: Cancer J
Continuous culture of urine-derived bladder cancer cells for precision medicine.
Authors: Jiang, Shuai, Wang, Jiaqi, Yang, Chen, Tan, Renke, Hou, Jun, Shi, Yuan, Zhang, Huihui, Ma, Shiyu, Wang, Jianan, Zhang, Mengmeng, Philips, George, Li, Zengxia, Ma, Jian, Yu, Wanjun, Wang, Guohua, Wu, Yuanming, Schlegel, Richard, Wang, Huina, Cao, Shanbo, Guo, Jianming, Liu, Xuefeng, Dang, Yongjun
Journal: Protein Cell
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, OTHER: Clinical Observation, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: Cystoscopy, PROCEDURE: CT Urography
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Gemcitabine Hydrochloride, DRUG: Eribulin Mesylate
Lead Sponsor: Weill Medical College of Cornell University
Collaborators: United States Department of Defense
Intervention / Treatment: DRUG: 111In-J591, DRUG: Hydrocortisone, DRUG: Ketoconazole, DRUG: 177Lu-J591